| Affiliation: | 1. Royal Marsden Hospital NHS Foundation Trust, London, UK;2. Department of Medical Oncology, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale dei Tumori, Milan, Italy;3. Melanoma, Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione Pascale, Naples, Italy;4. Dermatooncology Department, General University Hospital, Prague, Czech Republic;5. Ella Institute for Melanoma, Sheba Medical Center, Tel Hashomer, Israel;6. Universitair Ziekenhuis Brussel, Brussels, Belgium;7. Service of Oncology-Hospital La Paz, Madrid, Spain;8. Universität Tübingen-Hautklinik, Tübingen, Germany;9. Melanoma Oncology Unit, Veneto Oncology Institute, Gattamelata, Padova, Italy;10. Medical Oncology, University of Athens, Greece;11. Lady Davis Institute and Segal Cancer Centre, Jewish General Hospital, McGill University, Montreal, QC, Canada;12. Papa Giovanni XXIII Hospital, Bergamo, Italy;13. Department of Medical Oncology, University of Groningen, University Medical Centre Groningen, Groningen, Netherlands;14. Department of Medical Oncology, Hospital Clínic, Barcelona, Spain;15. IRCCS San Martino Hospital-IST, Genoa, Italy;p. University Hospital Schleswig-Holstein, Department of Dermatology, Kiel, Germany;q. Cancer Clinical Trials Unit, Royal Adelaide Hospital, and Centre for Cancer Biology, SA Pathology, Adelaide, SA, Australia;r. F Hoffmann-La Roche, Basel, Switzerland;s. Netherlands Cancer Institute–Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands |
